RECALLS AND SAFETY ALERTS MARKETING OF TRASYLOL SUSPENDED
January 7, 2008
Bayer Pharmaceuticals has suspended the marketing of Trasylol (aprotinin) which is used to reduce perioperative blood loss during cardiac surgery with cardiopulmonary bypass. Preliminary results of a Canadian study indicate that while patients given...
Additional Legal Resources: